Stephen Johnson

Array ( [id] => 7619991 [patent_doc_number] => 06943192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate' [patent_app_type] => utility [patent_app_number] => 09/863035 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8960 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943192.pdf [firstpage_image] =>[orig_patent_app_number] => 09863035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6896423 [patent_doc_number] => 20010027213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Use of pyrethroid compounds to promote hair growth' [patent_app_type] => new [patent_app_number] => 09/858929 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3963 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20010027213.pdf [firstpage_image] =>[orig_patent_app_number] => 09858929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 996627 [patent_doc_number] => 06914067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-05 [patent_title] => 'Compositions and methods for the treatment of colorectal cancer' [patent_app_type] => utility [patent_app_number] => 09/853619 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7862 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/914/06914067.pdf [firstpage_image] =>[orig_patent_app_number] => 09853619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033512 [patent_doc_number] => 20020019399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Therapeutic agents for drug dependence' [patent_app_type] => new [patent_app_number] => 09/850431 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3086 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019399.pdf [firstpage_image] =>[orig_patent_app_number] => 09850431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6409042 [patent_doc_number] => 20020037933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Management of septic shock' [patent_app_type] => new [patent_app_number] => 09/849591 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7703 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037933.pdf [firstpage_image] =>[orig_patent_app_number] => 09849591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403364 [patent_doc_number] => 20020037327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Treatment for cancer and compounds for use therein' [patent_app_type] => new [patent_app_number] => 09/850524 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4964 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037327.pdf [firstpage_image] =>[orig_patent_app_number] => 09850524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476895 [patent_doc_number] => 20020022608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Use of tetracycline derivatives in treating multiple sclerosis' [patent_app_type] => new [patent_app_number] => 09/848139 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6109 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022608.pdf [firstpage_image] =>[orig_patent_app_number] => 09848139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164126 [patent_doc_number] => 06759397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-06 [patent_title] => 'Ginsenoside chemotherapy' [patent_app_type] => B2 [patent_app_number] => 09/847155 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 3218 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759397.pdf [firstpage_image] =>[orig_patent_app_number] => 09847155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368174 [patent_doc_number] => 20040092549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Methods and compositions for selective cancer chemotherapy' [patent_app_type] => new [patent_app_number] => 09/830912 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3395 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092549.pdf [firstpage_image] =>[orig_patent_app_number] => 09830912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016899 [patent_doc_number] => 20020103141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Antiangiogenic combination therapy for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 09/843132 [patent_app_country] => US [patent_app_date] => 2001-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52837 [patent_no_of_claims] => 181 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103141.pdf [firstpage_image] =>[orig_patent_app_number] => 09843132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467448 [patent_doc_number] => 06458840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-01 [patent_title] => 'Use of valproic acid analog for the treatment and prevention of migraine and affective illness' [patent_app_type] => B2 [patent_app_number] => 09/840376 [patent_app_country] => US [patent_app_date] => 2001-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8058 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458840.pdf [firstpage_image] =>[orig_patent_app_number] => 09840376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440235 [patent_doc_number] => 06495517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Cyclooxygenase inhibitor' [patent_app_type] => B2 [patent_app_number] => 09/838125 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2598 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495517.pdf [firstpage_image] =>[orig_patent_app_number] => 09838125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6886767 [patent_doc_number] => 20010020036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => '5HT1 receptor agonists and metoclopramide for the treatment of migraine' [patent_app_type] => new [patent_app_number] => 09/838440 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4247 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20010020036.pdf [firstpage_image] =>[orig_patent_app_number] => 09838440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921778 [patent_doc_number] => 20010029263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Novel pyrrolidine carboxylate hair revitalizing agents' [patent_app_type] => new [patent_app_number] => 09/825896 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5282 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029263.pdf [firstpage_image] =>[orig_patent_app_number] => 09825896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477237 [patent_doc_number] => 20020022627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Inhibition of cyclooxygenase-2activity' [patent_app_type] => new [patent_app_number] => 09/823057 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2347 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022627.pdf [firstpage_image] =>[orig_patent_app_number] => 09823057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000715 [patent_doc_number] => 20020028845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => '6-methoxy-2-naphthylacetic acid prodrugs' [patent_app_type] => new [patent_app_number] => 09/823000 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9045 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028845.pdf [firstpage_image] =>[orig_patent_app_number] => 09823000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225365 [patent_doc_number] => 20020004500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Vasopeptidase Inhibitors to treat isolated systolic hypertension' [patent_app_type] => new [patent_app_number] => 09/819549 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1976 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004500.pdf [firstpage_image] =>[orig_patent_app_number] => 09819549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015122 [patent_doc_number] => 20010051624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Method and compositions for the treatment of allergic conditions using PGD2 receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/818885 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8016 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051624.pdf [firstpage_image] =>[orig_patent_app_number] => 09818885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046885 [patent_doc_number] => 06864280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-08 [patent_title] => 'γ-Tocotrienol-containing diuretics' [patent_app_type] => utility [patent_app_number] => 10/239945 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 2567 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864280.pdf [firstpage_image] =>[orig_patent_app_number] => 10239945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546596 [patent_doc_number] => 20020137787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitus' [patent_app_type] => new [patent_app_number] => 09/812410 [patent_app_country] => US [patent_app_date] => 2001-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2368 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137787.pdf [firstpage_image] =>[orig_patent_app_number] => 09812410 [rel_patent_id] =>[rel_patent_doc_number] =>)